Streptokinase: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
* [https://www.drugs.com/monograph/streptokinase.html Streptokinase] on Drugs.com | * [https://www.drugs.com/monograph/streptokinase.html Streptokinase] on Drugs.com | ||
* [https://www.ncbi.nlm.nih.gov/pubmed/202051 Streptokinase] on PubMed | * [https://www.ncbi.nlm.nih.gov/pubmed/202051 Streptokinase] on PubMed | ||
==Streptokinase== | |||
<gallery> | |||
File:Sk_surface_3.png|Streptokinase surface model | |||
File:PDB_2sak_EBI.jpg|Streptokinase PDB structure | |||
File:Saltbridge_1.png|Streptokinase salt bridge | |||
File:Sk-plgn_57.png|Streptokinase-plasminogen complex | |||
</gallery> | |||
Latest revision as of 04:48, 18 February 2025
Streptokinase is a thrombolytic medication and enzyme produced by streptococci bacteria. It is used to break down clots in some cases of myocardial infarction (heart attack), pulmonary embolism, and arterial thromboembolism. The use of streptokinase is contraindicated in cases of recent surgery, hemorrhagic stroke, or active bleeding.
Mechanism of Action[edit]
Streptokinase works by combining with plasminogen to form an active complex that can convert other plasminogen molecules into plasmin. Plasmin is an enzyme that breaks down fibrin, a protein that forms the framework of blood clots.
Side Effects[edit]
Common side effects of streptokinase include nausea, vomiting, low blood pressure, and bleeding. Serious side effects may include allergic reactions and major bleeding.
History[edit]
Streptokinase was discovered in 1933. It was the first thrombolytic medication to be approved for use in heart attacks.
See Also[edit]
|
|
|
References[edit]
<references />
External Links[edit]
- Streptokinase on Drugs.com
- Streptokinase on PubMed
Streptokinase[edit]
-
Streptokinase surface model
-
Streptokinase PDB structure
-
Streptokinase salt bridge
-
Streptokinase-plasminogen complex


